MDY Mdy Healthcare

RNS No 5008x
MEDISYS PLC
15 July 1999
        
                              MEDISYS PLC

                     Acquisition of Futura Safety Syringe

Medisys PLC ("Medisys") announces that, further to its announcement of 21 June
1999, it completed the acquisition of the worldwide rights of the Futura
safety syringe and related technology from Adventec, Inc. ("Adventec") on 14
July 1999.

Initial consideration was satisfied by the issue of 833,000 Medisys ordinary
shares to Adventec.  Further consideration totalling 1,167,000 Medisys
ordinary shares will be paid to the vendors upon the Futura receiving FDA 510K
approval.  Further milestone payments will become due upon commercialisation
of the product.   

Kurt E. Amundson, President & Chief Operating Officer of Medisys, said: "I am
pleased we have completed the Futura acquisition on schedule.  Ownership of
this innovative and cost efficient safety syringe technology will enable us to
take advantage of the introduction of US safety legislation and build a strong
position in this rapidly growing market.  Our efforts will now be focused on
our application for FDA approval early in 2000."

Rob Adam, President of Adventec said: "We have concluded this deal with
Medisys after an extensive search for the right commercial partner, which
included negotiations with a number of much larger companies.  In choosing
Medisys, we believe we have selected the best partner to ensure a rapid
commercialisation of the Futura technology."

Note to editors:

Medisys PLC develops, manufactures and markets diagnostic, medical and safety
products serving the rapid test and point of care medical market.  The Group
has two principal operating subsidiaries, Hypoguard and Lukens, located in the
UK and in the US respectively.  The diagnostic division develops and supplies
blood glucose monitoring systems for the diabetic market.  Its future focus is
on serving unmet medical needs through the development of diagnostic products
based on its own proprietary platform technologies.  Headquartered in Ipswich,
UK, the Group employs approximately 225 people in the UK and US.

Enquiries:

Medisys PLC                            
Kurt Amundson, President & Chief Operating Officer         001 650 327 7900
Michael Barry, Chief Financial Officer                     001 770 271 2795

Square Mile Communications                                    0171 601 1000
Kevin Smith/James Melville-Ross


END

ACQCCPCQPDKDAOD

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024